This Oncology Drug Discovery course at Queen's University Belfast will include an industrial viewpoint into what makes an interesting target and how, through an iterative process, this target is validated.
In addition, lectures will be provided to discuss how ‘hit’ compounds are identified, in both the academic and industrial setting, using compound screen assays and fragment based screening technologies. We will also provide an insight in computational methods for generating chemical ‘hits’.
The module will also cover how these ‘hit’ compounds are prosecuted into tool compounds or Lead Optimisation candidates (LO), both historic and modern, that are used to further validate a potential drug target.
During this second module we will provide an insight into the challenges of moving a compound from an LO candidate to a pre-clinical candidate. How bio-marker companion tests are developed, validated and are used to underpin clinical trials.
The lectures will also provide a keen insight into novel formulation strategies currently under development within Queen’s University Belfast. In addition, we will also provide an insight into the development of bio-therapeutics, such as antibodies, that are proving to be a powerful alternative to small molecule based therapeutics.
Oncology Drug Discovery Highlights
The strong links between us and the biotech and bio-pharmaceutical sectors provides a stimulating translational environment, while also expanding your career opportunities.
The partnership with the National Cancer Institute (NCI) and the School of Medicine, Dentistry & Biomedical Sciences provides opportunity to study in the USA. This 4-year Doctoral Training Programme (DTP) provides students the opportunity to undertake a postgraduate taught programme in Year 1 at QUB (refer to link below for full list of programmes), followed by a PhD at NCI in Years 2-4.
More informationVisit official programme website
- Research Translation from concept to commercialisation
- Diagnosis and treatment of cancer
- Cancer Biology
- Cancer Drug Target Identification
- Processes required to validate a new Drug Target
- Compound ‘hit’ identification
- 12 months
Start dates & application deadlines
- Apply before
DisciplinesBiomedicine Pharmacy Biotechnology View 203 other Masters in Biomedicine in United Kingdom
- Normally a minimum of a 2.1 Honours degree, or equivalent qualification acceptable to the University, in chemistry, biochemistry, pharmacology, medicinal chemistry or other related and relevant subject acceptable to the University. Evidence of equivalent professional qualifications (MBBS, BDS or BVSc) or experience will be considered on an individual basis.
International20800 GBP/yearTuition FeeBased on the original amount of 20800 GBP per year and a duration of 12 months.
EU/EEA6140 GBP/yearTuition FeeBased on the original amount of 6140 GBP per year and a duration of 12 months.
England, Scotland or Wales (GB) £6,900
Studyportals Tip: Students can search online for independent or external scholarships that can help fund their studies. Check the scholarships to see whether you are eligible to apply. Many scholarships are either merit-based or needs-based.
Apply and win up to €10000 to cover your tuition fees.
Updated in the last 9 months
Check the official programme website for potential updates.